The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Self-citationTakeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Self-citationPodolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,159
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Commensal Host-Bacterial Relationships in the Gut
Hooper, L. V., & Gordon, J. I. (2001) · Science · doi:10.1126/science.1058709 · Cited by 2,362
Innate immune recognition: mechanisms and pathways
Medzhitov, R., & Janeway, C. J. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917309.x · Cited by 1,506
Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., & Campieri, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.9370 · Cited by 1,486
The Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L., & De Simone, C. (2001) · Gastroenterology · doi:10.1053/gast.2001.27224 · Cited by 1,102
Cited by
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Abreu, M. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2707 · Cited by 1,288
“A similar reduction in DSS-induced colitis was observed following oral or systemic administration of the TLR9 ligand CpG OD”
BackgroundSartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,052
Genes and Molecules of Lactobacilli Supporting Probiotic Action
Lebeer, S., Vanderleyden, J., & De Keersmaecker, S. C. J. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00017-08 · Cited by 1,013
“DNA of the probiotic cocktail VSL#3 has been shown to exert a systemically induced protective effect against dextran sulfate sodium-induced colitis mediated by TLR9 (198).”
BackgroundInfluentialImmunomodulatory functions of type I interferons
González-Navajas, J. M., Lee, J., David, M., & Raz, E. (2012) · Nature Reviews Immunology · doi:10.1038/nri3133 · Cited by 1,011
Self-citationLin, P. W., & Stoll, B. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69525-1 · Cited by 848
Mucosal healing in inflammatory bowel diseases: a systematic review
Neurath, M. F., & Travis, S. P. L. (2012) · Gut · doi:10.1136/gutjnl-2012-302830 · Cited by 810
Smits, H. H., Engering, A., van der Kleij, D., de Jong, E. C., Schipper, K., van Capel, T. M. M., Zaat, B. A. J., Yazdanbakhsh, M., Wierenga, E. A., & van Kooyk, Y. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.03.036 · Cited by 766
Mechanisms of probiotic actions – A review
Oelschlaeger, T. A. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2009.08.005 · Cited by 719
Taverniti, V., & Guglielmetti, S. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0218-x · Cited by 703
“The anti-inflammatory effect of genomic DNA from VSL#3 bacteria was also confirmed in an in vivo murine study, which demonstrated that TLR9 signalling was essential in mediating this anti-inflammatory effect ( Rachmilewitz et al. 2004 ).”
BackgroundOtt, S. J., Waetzig, G. H., Rehman, A., Moltzau-Anderson, J., Bharti, R., Grasis, J. A., Cassidy, L., Tholey, A., Fickenscher, H., Seegert, D., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.010 · Cited by 695
Current and emerging therapeutic targets for IBD
Neurath, M. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.208 · Cited by 691
Probiotics: Definition, Sources, Selection, and Uses
Sanders, M. E. (2008) · Clinical Infectious Diseases · doi:10.1086/523341 · Cited by 661
Cosnes, J., Nion-Larmurier, I., Beaugerie, L., Afchain, P., Tiret, E., & Gendre, J.-P. (2005) · Gut · doi:10.1136/gut.2004.045294 · Cited by 657
Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease
Schröder, N. W., & Schumann, R. R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01308-3 · Cited by 638
Lee, J., Mo, J.-H., Katakura, K., Alkalay, I., Rucker, A. N., Liu, Y.-T., Lee, H.-K., Shen, C., Cojocaru, G., Shenouda, S., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1500 · Cited by 623
Self-citationMechanisms of action of probiotics: Recent advances
Ng, S. C., Hart, A. L., Kamm, M. A., Stagg, A. J., & Knight, S. C. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20602 · Cited by 596
Scholz-Ahrens, K. E., Ade, P., Marten, B., Weber, P., Timm, W., Asil, Y., Glüer, C.-C., & Schrezenmeir, J. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.838s · Cited by 591
Mizoguchi, A., & Bhan, A. K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.705 · Cited by 582
TLR Signaling in the Gut in Health and Disease
Abreu, M. T., Fukata, M., & Arditi, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4453 · Cited by 581
Iwasaki, A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141634 · Cited by 534
Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W., & Boirivant, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3237 · Cited by 524
Miele, E., Pascarella, F., Giannetti, E., Quaglietta, L., Baldassano, R. N., & Staiano, A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.118 · Cited by 517
The probiotic paradox: live and dead cells are biological response modifiers
Adams, C. A. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000090 · Cited by 521
The impact of perinatal immune development on mucosal homeostasis and chronic inflammation
Renz, H., Brandtzaeg, P., & Hornef, M. (2012) · Nature Reviews Immunology · doi:10.1038/nri3112 · Cited by 510
Fukata, M., Michelsen, K. S., Eri, R., Thomas, L. S., Hu, B., Lukasek, K., Nast, C. C., Lechago, J., Xu, R., Naiki, Y., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00328.2004 · Cited by 506
Borchers, A. T., Selmi, C., Meyers, F. J., Keen, C. L., & Gershwin, M. E. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2296-0 · Cited by 499
Hall, J. A., Bouladoux, N., Sun, C. M., Wohlfert, E. A., Blank, R. B., Zhu, Q., Grigg, M. E., Berzofsky, J. A., & Belkaid, Y. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.009 · Cited by 494
The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells
Caballero-Franco, C., Keller, K., De Simone, C., & Chadee, K. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00265.2006 · Cited by 492
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., Rogler, G., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001308 · Cited by 482
“In the past years, probiotics have been shown to be effective in the treatment of mild to moderately active IBD [18] and to reduce inflammation in animal models of colitis [29,34–36].”
BackgroundProbiotic and other functional microbes: from markets to mechanisms
Saxelin, M., Tynkkynen, S., Mattila-Sandholm, T., & de Vos, W. M. (2005) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2005.02.003 · Cited by 484
Mennigen, R., Nolte, K., Rijcken, E., Utech, M., Loeffler, B., Senninger, N., & Bruewer, M. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90534.2008 · Cited by 483
Intestinal microbiota, diet and health
Power, S. E., O'Toole, P. W., Stanton, C., Ross, R. P., & Fitzgerald, G. F. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114513002560 · Cited by 476
Gut microbiota: a potential new territory for drug targeting
Jia, W., Li, H., Zhao, L., & Nicholson, J. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2505 · Cited by 475
Elson, C. O., Cong, Y., McCracken, V. J., Dimmitt, R. A., Lorenz, R. G., & Weaver, C. T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00291.x · Cited by 469
Regulatory T Cells in the Control of Host-Microorganism Interactions
Belkaid, Y., & Tarbell, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132723 · Cited by 468
Toll-like receptor 9–induced type I IFN protects mice from experimental colitis
Katakura, K., Lee, J., Rachmilewitz, D., Li, G., Eckmann, L., & Raz, E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22996 · Cited by 451
Self-citationSpecific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M. (2006) · Gut · doi:10.1136/gut.2005.066100 · Cited by 448
Grangette, C., Nutten, S., Palumbo, E., Morath, S., Hermann, C., Dewulf, J., Pot, B., Hartung, T., Hols, P., & Mercenier, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504084102 · Cited by 443
Using probiotics to improve swine gut health and nutrient utilization
Liao, S. F., & Nyachoti, M. (2017) · Animal Nutrition · doi:10.1016/j.aninu.2017.06.007 · Cited by 443
The Role of Intestinal Microbiota in the Development and Severity of Chemotherapy-Induced Mucositis
van Vliet, M. J., Harmsen, H. J. M., de Bont, E. S. J. M., & Tissing, W. J. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000879 · Cited by 436
Epithelial Toll-like receptors and their role in gut homeostasis and disease
Burgueño, J. F., & Abreu, M. T. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0261-4 · Cited by 395
Commensal gut bacteria: mechanisms of immune modulation
Kelly, D., Conway, S., & Aminov, R. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.04.008 · Cited by 393
Zoetendal, E. G., Vaughan, E. E., & De Vos, W. M. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05056.x · Cited by 389
The mechanism of action of probiotics
Boirivant, M., & Strober, W. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282f0cffc · Cited by 380
Prebiotics and Probiotics in Digestive Health
Quigley, E. M. M. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.09.028 · Cited by 380
Probiotics promote gut health through stimulation of epithelial innate immunity
Pagnini, C., Saeed, R., Bamias, G., Arseneau, K. O., Pizarro, T. T., & Cominelli, F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910307107 · Cited by 358
“Controlled studies have shown VSL#3 to be efficacious for patients with ulcerative colitis (UC) and pouchitis (8, 9), as well as in animal models of colitis (10, 11).”
BackgroundMethodCalcinaro, F., Dionisi, S., Marinaro, M., Candeloro, P., Bonato, V., Marzotti, S., Corneli, R. B., Ferretti, E., Gulino, A., Grasso, F., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1831-2 · Cited by 352
BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2
Cario, E. (2005) · Gut · doi:10.1136/gut.2004.062794 · Cited by 351
Cross-Talk between Probiotic Bacteria and the Host Immune System1,
Corthésy, B., Gaskins, H. R., & Mercenier, A. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.781s · Cited by 351
Vanderpool, C., Yan, F., & Polk, B. D. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20525 · Cited by 340
Toll-like receptors in inflammatory bowel diseases: A decade later
Cario, E. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21282 · Cited by 336
Kverka, M., Zakostelska, Z., Klimesova, K., Sokol, D., Hudcovic, T., Hrncir, T., Rossmann, P., Mrazek, J., Kopecny, J., Verdu, E. F., et al. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04286.x · Cited by 335
Microbes, immunoregulation, and the gut: Figure 1
Rook, G. A. W., & Brunet, L. R. (2005) · Gut · doi:10.1136/gut.2004.053785 · Cited by 334
Small Intestinal Bacterial Overgrowth: Roles of Antibiotics, Prebiotics, and Probiotics
Quigley, E. M. M., & Quera, R. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.046 · Cited by 329
Predominant Role of Host Genetics in Controlling the Composition of Gut Microbiota
Khachatryan, Z. A., Ktsoyan, Z. A., Manukyan, G. P., Kelly, D., Ghazaryan, K. A., & Aminov, R. I. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003064 · Cited by 322
Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders
Fukata, M., Vamadevan, A. S., & Abreu, M. T. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.06.005 · Cited by 320
Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T. A., Stange, E. F., & Fellermann, K. (2007) · Infection and Immunity · doi:10.1128/iai.01563-06 · Cited by 315
Robinson, D. S., Larché, M., & Durham, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423595 · Cited by 313
The Human Microbiome and Its Potential Importance to Pediatrics
Johnson, C. L., & Versalovic, J. (2012) · Pediatrics · doi:10.1542/peds.2011-2736 · Cited by 310
New targets for mucosal healing and therapy in inflammatory bowel diseases
Neurath, M. F. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.73 · Cited by 309
Oral Treatment with Live Lactobacillus reuteri Inhibits the Allergic Airway Response in Mice
Forsythe, P., Inman, M. D., & Bienenstock, J. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200606-821oc · Cited by 306
Role of the intestinal barrier in inflammatory bowel disease
Laukoetter, M. G., Nava, P., & Nusrat, A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.401 · Cited by 300
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
Kim, D. H., & Cheon, J. H. (2017) · Immune Network · doi:10.4110/in.2017.17.1.25 · Cited by 295
Zhang, L., Li, N., Caicedo, R., & Neu, J. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.7.1752 · Cited by 295
Van Gossum, A., Dewit, O., Louis, E., de Hertogh, G., Baert, F., Fontaine, F., DeVos, M., Enslen, M., Paintin, M., & Franchimont, D. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20063 · Cited by 295
The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis
Lavelle, E. C., Murphy, C., O'Neill, L. A. J., & Creagh, E. M. (2010) · Mucosal Immunology · doi:10.1038/mi.2009.124 · Cited by 293
Ma, D., Forsythe, P., & Bienenstock, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5308-5314.2004 · Cited by 289
A Key Role of Dendritic Cells in Probiotic Functionality
Foligne, B., Zoumpopoulou, G., Dewulf, J., Ben Younes, A., Chareyre, F., Sirard, J.-C., Pot, B., & Grangette, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000313 · Cited by 279
Ciorba, M. A., Riehl, T. E., Rao, M. S., Moon, C., Ee, X., Nava, G. M., Walker, M. R., Marinshaw, J. M., Stappenbeck, T. S., & Stenson, W. F. (2012) · Gut · doi:10.1136/gutjnl-2011-300367 · Cited by 277
Netea, M. G., Ferwerda, G., de Jong, D. J., Jansen, T., Jacobs, L., Kramer, M., Naber, T. H. J., Drenth, J. P. H., Girardin, S. E., Jan Kullberg, B., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6518 · Cited by 273
Velayudham, A., Dolganiuc, A., Ellis, M., Petrasek, J., Kodys, K., Mandrekar, P., & Szabo, G. (2009) · Hepatology · doi:10.1002/hep.22711 · Cited by 263
Wound healing of intestinal epithelial cells
Iizuka, M. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i17.2161 · Cited by 259
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis
Kühbacher, T., Ott, S. J., Helwig, U., Mimura, T., Rizzello, F., Kleessen, B., Gionchetti, P., Blaut, M., Campieri, M., Fölsch, U. R., et al. (2006) · Gut · doi:10.1136/gut.2005.078303 · Cited by 257
Gribar, S. C., Sodhi, C. P., Richardson, W. M., Anand, R. J., Gittes, G. K., Branca, M. F., Jakub, A., Shi, X.-H., Shah, S., Ozolek, J. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.636 · Cited by 257
Recent understanding of IBD pathogenesis: Implications for future therapies
Kucharzik, T., Maaser, C., Lügering, A., Kagnoff, M., Mayer, L., Targan, S., & Domschke, W. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000235827.21778.d5 · Cited by 254
The role of pattern recognition receptors in intestinal inflammation
Fukata, M., & Arditi, M. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.13 · Cited by 253
Kamiya, T., Wang, L., Forsythe, P., Goettsche, G., Mao, Y., Wang, Y., Tougas, G., & Bienenstock, J. (2006) · Gut · doi:10.1136/gut.2005.070987 · Cited by 242
Prebiotics and probiotics; modifying and mining the microbiota
Quigley, E. M. M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.004 · Cited by 238
Review article: probiotics and prebiotics in irritable bowel syndrome
SPILLER, R. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03750.x · Cited by 190
Aslam, H., Green, J., Jacka, F. N., Collier, F., Berk, M., Pasco, J., & Dawson, S. L. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1544332 · Cited by 179
Eutamene, H., Lamine, F., Chabo, C., Theodorou, V., Rochat, F., Bergonzelli, G. E., Corthésy-Theulaz, I., Fioramonti, J., & Bueno, L. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.8.1901 · Cited by 169
Parkes, G. C., Brostoff, J., Whelan, K., & Sanderson, J. D. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01869.x · Cited by 167
“In a murine model of colitis, gamma-irradiated, nonviable probiotics were shown to have an equal anti-inflammatory effect to viable probiotic bacteria (84).”
BackgroundProbiotic Effects on Inflammatory Bowel Disease1,
Sheil, B., Shanahan, F., & O’Mahony, L. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.3.819s · Cited by 167
Quigley, E. M. M., & Flourie, B. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00879.x · Cited by 151
Probiotic mixture VSL# 3: An overview of basic and clinical studies in chronic diseases
Cheng, F.-S., Pan, D., Chang, B., Jiang, M., & Sang, L.-X. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i8.1361 · Cited by 147
Choi, C. H., Jo, S. Y., Park, H. J., Chang, S. K., Byeon, J.-S., & Myung, S.-J. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318204593e · Cited by 144
How bile acids and the microbiota interact to shape host immunity
Lee, M. H., Nuccio, S.-P., Mohanty, I., Hagey, L. R., Dorrestein, P. C., Chu, H., & Raffatellu, M. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-024-01057-x · Cited by 143
Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
(2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8886 · Cited by 106
Probiotics: Immunomodulation and Evaluation of Safety and Efficacy
Ezendam, J., & Loveren, H. (2006) · Nutrition Reviews · doi:10.1111/j.1753-4887.2006.tb00168.x · Cited by 103
Rong, J., Zheng, H., Liu, M., Hu, X., Wang, T., Zhang, X., Jin, F., & Wang, L. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0525-2 · Cited by 99
“Macroscopic lesions were evaluated according to the Wallace criteria [30].”
BackgroundMethodTLR9 is important for protection against intestinal damage and for intestinal repair
II, W. A. R., Sakamoto, K., & Leifer, C. A. (2012) · Scientific Reports · doi:10.1038/srep00574 · Cited by 84
NOD-like receptors in intestinal homeostasis and epithelial tissue repair
Parlato, M., & Yeretssian, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069594 · Cited by 79
Using Probiotics in Gastrointestinal Disorders
Ringel, Y., Quigley, E. M., & Lin, H. C. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.7 · Cited by 77
Quigley, E. M. M. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.009 · Cited by 67
Serotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity
Bueno, L., De Ponti, F., Fried, M., Kullak‐ublick, G. A., Kwiatek, M. A., Pohl, D., Quigley, E. M. M., Tack, J., & Talley, N. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00876.x · Cited by 64
Lata, J. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i24.2890 · Cited by 58
Darb Emamie, A., Rajabpour, M., Ghanavati, R., Asadolahi, P., Farzi, S., Sobouti, B., & Darbandi, A. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.14907 · Cited by 57
Metadata
- Authors
- Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., & Raz, E.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 126
- Issue
- 2
- Pages
- 520-528
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2114424280
- Cited by
- 859
- References
- 23
- FWCI
- 139.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.